ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,010 | +1080.4% | 251,181 | +1147.2% | 0.16% | +1250.0% |
| Q2 2023 | $1,441 | -90.7% | 20,139 | -91.0% | 0.01% | -90.6% |
| Q1 2023 | $15,473 | -99.5% | 222,926 | +284.9% | 0.13% | +204.8% |
| Q3 2022 | $3,176,000 | +682.3% | 57,915 | +845.4% | 0.04% | +740.0% |
| Q1 2022 | $406,000 | +6.8% | 6,126 | -6.0% | 0.01% | +25.0% |
| Q4 2021 | $380,000 | -91.4% | 6,520 | -91.2% | 0.00% | -93.3% |
| Q3 2021 | $4,425,000 | +16.2% | 73,683 | +15.9% | 0.06% | +42.9% |
| Q2 2021 | $3,809,000 | +353.5% | 63,592 | +278.3% | 0.04% | +425.0% |
| Q4 2020 | $840,000 | -27.1% | 16,811 | -20.1% | 0.01% | -65.2% |
| Q3 2020 | $1,153,000 | -61.1% | 21,038 | -62.5% | 0.02% | -70.1% |
| Q2 2020 | $2,962,000 | +412.5% | 56,037 | +299.9% | 0.08% | +234.8% |
| Q2 2019 | $578,000 | +28.7% | 14,013 | +26.3% | 0.02% | -30.3% |
| Q1 2019 | $449,000 | – | 11,094 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |